Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sensus Healthcare Inc SRTS

Healthcare Medical Devices
Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon... see more

Recent & Breaking News (NDAQ:SRTS)

REVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter

GlobeNewswire 5 days ago

Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter

GlobeNewswire 8 days ago

Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024

GlobeNewswire October 31, 2024

Sensus Healthcare Sells SRT System to Providence Swedish Hospital

GlobeNewswire September 25, 2024

Sensus Healthcare Reports Second Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Second Quarter

GlobeNewswire August 8, 2024

Sensus Healthcare Issues Reminder That its Second Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, August 8, 2024

GlobeNewswire August 1, 2024

Sensus Healthcare to Host Second Quarter 2024 Financial Results and Business Update Conference Call on Thursday, August 8, 2024

GlobeNewswire July 25, 2024

Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold

GlobeNewswire May 9, 2024

Largest Veterinary Emergency Hospital in Tel Aviv Acquires Sensus Healthcare's SRT-100(TM) to Provide Gentler Radiotherapy to Treat Tumors in Dogs and Cats

GlobeNewswire May 9, 2024

Sensus Healthcare Announces Sale of First SRT-100 Vision(TM) System to Asia

GlobeNewswire May 6, 2024

Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024

GlobeNewswire April 25, 2024

Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024

GlobeNewswire April 18, 2024

Sensus Healthcare to Participate in the 36th Annual Roth Conference

GlobeNewswire March 14, 2024

Sensus Healthcare Launches "Fair Deal Agreement" for its SRT-100 Vision(TM) at the American Academy of Dermatology Annual Meeting

GlobeNewswire March 13, 2024

Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire February 8, 2024

Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities

GlobeNewswire February 8, 2024

Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements

GlobeNewswire February 6, 2024

Sensus Healthcare Announces Retirement of Director Samuel O'Rear

GlobeNewswire February 1, 2024

Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024

GlobeNewswire January 30, 2024

Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million

GlobeNewswire January 23, 2024